| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/10/2007 | WO2007009822A3 Method for the quantification of methylated dna |
| 05/10/2007 | WO2007006862A3 Method and kit for detecting a risk of coronary heart disease |
| 05/10/2007 | WO2007004526A3 Identification of compounds modulating the smyd3 transferase for the treatment of cancer |
| 05/10/2007 | WO2006138225B1 A novel and practical serological assay for the clinical diagnosis of leishmaniasis |
| 05/10/2007 | WO2006133446A9 Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes |
| 05/10/2007 | WO2006130990A3 Detecting electrical activity and assessing agents for the ability to influence electrical activity in neuronal cell networks |
| 05/10/2007 | WO2006120406A3 Gene over-expression in d. discoideum for identifying farnesyl diphosphate synthase antagonists useful for treating bone diseases |
| 05/10/2007 | WO2006112713A3 High throughput screening method for assessing heterogeneity of microorganisms |
| 05/10/2007 | WO2006105597A8 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 05/10/2007 | WO2006105414A3 Apparatus and method for detecting microscopic organisms using microphage |
| 05/10/2007 | WO2006102177A3 Biomarkers for efficacy of aliskiren as a hypertensive agent |
| 05/10/2007 | WO2006097506A3 Method and test kit for detecting target nucleic acids |
| 05/10/2007 | WO2006086772A3 DIAGNOSING AND TREATING CANCER USING β-CATENIN SPLICE VARIANTS |
| 05/10/2007 | WO2006083657A3 Genetic markers associated with benign prostatic hyperplasia |
| 05/10/2007 | WO2006058245A3 Dielectrophoretic particle sorter |
| 05/10/2007 | WO2006050062A3 Polymerase-based protocols for the introduction of deletions and insertions |
| 05/10/2007 | WO2006036173A3 Frizzled proteins and detection and treatment of cancer |
| 05/10/2007 | WO2006026714A8 Diagnosis and prognosis of cancer based on telomere length as measured on cytological specimens |
| 05/10/2007 | WO2006023880A3 Compounds and methods for the characterization of oligonucleotides |
| 05/10/2007 | WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease |
| 05/10/2007 | WO2005121373A3 Hybridization of pna probes in alcohol solutions |
| 05/10/2007 | WO2005089254A3 A method of evaluating freshness of a fish product |
| 05/10/2007 | WO2005080601A3 Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling |
| 05/10/2007 | WO2004103296A3 Methods of treating idiopathic pulmonary fibrosis |
| 05/10/2007 | WO2004045521A3 Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimaker quantitative rt-pcr |
| 05/10/2007 | US20070107073 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 05/10/2007 | US20070107070 Invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 05/10/2007 | US20070106333 Integrated biosensor and simulation system for diagnosis and therapy |
| 05/10/2007 | US20070106069 Non-Human Primate Fc Receptors and Methods of Use |
| 05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105931 Methods and compositions for inhibiting the proliferation of prostate cancer cells |
| 05/10/2007 | US20070105809 Modulators of coagulation factors with enhanced stability |
| 05/10/2007 | US20070105808 Inhibition of histone deacetylase |
| 05/10/2007 | US20070105798 Method of Converting Base in DNA Sequence |
| 05/10/2007 | US20070105797 Antisense inhibition of laminin-8 expression to inhibit human gliomas |
| 05/10/2007 | US20070105796 Method for inhibiting telomerase activity and inhibitor thereof |
| 05/10/2007 | US20070105795 Gene expression suppression agents |
| 05/10/2007 | US20070105772 Induction of Apoptosis by Cellular Stress |
| 05/10/2007 | US20070105771 Anti-CD26 antibodies and methods of use thereof |
| 05/10/2007 | US20070105764 Fusion protein for controlling production of proteins in bioreactor: cellular therapy (somatic gene therapy); antiviral therapies |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105219 Retrovirus from the HIV group and its use |
| 05/10/2007 | US20070105218 Lupus antibodies for passive immunotherapy of hiv/aids |
| 05/10/2007 | US20070105194 diploid yeast strain; virus-like particle (VLP) comprising a first late 1 (L1) capsid protein from human papilloma virus (HPV) type 6 and a second L1 capsid protein from HPV type 16; Saccharomyces cerevisiae |
| 05/10/2007 | US20070105193 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070105188 determining sperm quality, and different storage media's effect thereon; male fertility |
| 05/10/2007 | US20070105186 Method for preserving microbial cells |
| 05/10/2007 | US20070105185 transdermal patches comprising flexible substrates, rigid pads and sample receiving surfaces configured for holding samples for in vivo or in vitro use |
| 05/10/2007 | US20070105184 Biosensor method and system based on feature vector extraction |
| 05/10/2007 | US20070105182 modified by substituting negatively charged amino acids with positively charged amino acids on the exterior of the protein making the protein cell permeable; obviates the need for transfections |
| 05/10/2007 | US20070105181 Identification of cancer biomarkers and phosphorylated pdroteins |
| 05/10/2007 | US20070105180 Methods for detecting sleepiness |
| 05/10/2007 | US20070105179 Methods of detecting N-and O-linked oligosaccharides in glycoproteins |
| 05/10/2007 | US20070105178 a purified neural precursor cell-expressed developmentally down regulated (NEDD)8-activating protein beta subunit (NAE1-beta), used for detecting and/or modulating the conjugation of NEDD8 and/or its transfer to a target proteins |
| 05/10/2007 | US20070105177 Method for detecting analyte in sample, method for quantifying activity of enzyme, and method for quantifying protein in sample |
| 05/10/2007 | US20070105176 for sensing glucose may include contacting a fluorescein, a rhodamine, a cyanine, or a fluorescent dye linked ligand (e.g., dextran or dendrimer e.g. glycosyloxyethyl methacrylate ) and a sugar-binding lectin (e.g., Concanavalin A) with a test sample |
| 05/10/2007 | US20070105175 Method for improving heat stability of composition containing water-soluble coenzyme-bound glucose dehydrogenase (GDH) |
| 05/10/2007 | US20070105174 Novel glucose dehydrogenase |
| 05/10/2007 | US20070105173 Modified pyrroloquinoline quinone (pqq) dependent glucose dehydrogenase excellent in substrate specificity |
| 05/10/2007 | US20070105172 A gene construct incorporating any two luciferase genes which emit lights with different colors using an identical substrate such that the gene can be stably expressed in mammalian cells; optimize a reporter gene capable of determining or quantifying multiple transcription activities simultaneosly |
| 05/10/2007 | US20070105167 Virulence Associated Nucleic Acid Sequences and Uses Thereof |
| 05/10/2007 | US20070105166 Determining level of Neutrophil Gelatinase-Associated Lipocalin in urine to detect for presence of cancer; matrix metalloproteinases |
| 05/10/2007 | US20070105163 Flow-controlled magnetic particle manipulation |
| 05/10/2007 | US20070105160 Detection of intracellular enzyme complex |
| 05/10/2007 | US20070105159 Identifying compound that modulates signal transduction by measuring its binding and comparing to sugar; G-protein coupled receptor polypeptide |
| 05/10/2007 | US20070105153 Maternal Antigen That Embryos Require (MATER); Recognizing epitope by detecting binding; indicative of infertility |
| 05/10/2007 | US20070105148 Sphingosine 1-phosphate receptor gene, SPPR |
| 05/10/2007 | US20070105147 Rapid method for screening compounds for in vivo activity |
| 05/10/2007 | US20070105146 Detection of susceptibility to autoimmune diseases |
| 05/10/2007 | US20070105145 field of combination oligomers, including the block synthesis of combination oligomers in the absence of a template, as well as related methods, kits, libraries and other compositions. |
| 05/10/2007 | US20070105144 Method of nucleic acid analysis |
| 05/10/2007 | US20070105143 Novel bHLH type transcription factor genes |
| 05/10/2007 | US20070105142 Methods for prognosis and monitoring cancer therapy |
| 05/10/2007 | US20070105141 isolated cell having azetidinone cholesterol absorption inhibitor binded to the surface; measuring fluorescence; competitive binding assays; anticholesterol agents; as a tool for discovering proteins involved in absorption of cholesterol |
| 05/10/2007 | US20070105139 Fluorescent probe and fluorescence detecting method |
| 05/10/2007 | US20070105138 generating a signal indicative of the presence of a target nucleic acid in a sample by forming a cleavage structure through incubating a sample with a probe containing a binding moiety and having a secondary structure that changes upon binding and cleaving the cleavage structure with a nuclease |
| 05/10/2007 | US20070105137 Determining whether a naturally occurring strain of algae is toxic, comprisingdetermining whether a sample obtained from said strain of algae comprises a nucleic acid encoding a specific polypeptide; harmful algal blooms; shellfish; gene expression |
| 05/10/2007 | US20070105136 Methods for identifying, diagnosing, and predicting survival of lymphomas |
| 05/10/2007 | US20070105135 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/10/2007 | US20070105134 Hyperparathyroidism; determining which alleles for a calcium-sensitive receptor (CaSR) gene the subject carries; drug screening |
| 05/10/2007 | US20070105133 Compositions and methods for treating and diagnosing cancer |
| 05/10/2007 | US20070105132 Nucleic acid sequencing by Raman monitoring of uptake of nucleotides during molecular replication |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | US20070105130 determining the degree of ubiquitination of Fanconi anemia complementation group D2 (FANC D2); inhibitors of Fanconi anemia pathway useful in inhibiting DNA damage repair |
| 05/10/2007 | US20070105129 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 05/10/2007 | US20070105128 Detection of genetic polymorphisms |
| 05/10/2007 | US20070105126 calibrating temperature via cycling temperatures of set of wells, each containing sample with spectrally distinguishable species |
| 05/10/2007 | US20070105125 Chemical array housing having a gas delivery element and methods of using the same |
| 05/10/2007 | US20070105124 for gene expression studies involving nucleic acid microarrays; synthesizing asRNA (antisense RNA) molecule directly from sRNA molecule; provides increased amplification with low amounts of non-specific artifacts |
| 05/10/2007 | US20070105123 IRE-1alpha substrates |
| 05/10/2007 | US20070105122 Primers for synthesizing full-length cDNA and their use |
| 05/10/2007 | US20070105121 Method for the detection of schizophrenia related gene transcripts in blood |
| 05/10/2007 | US20070105120 Method of identifying/designing and/or modifying chemical species capable of interacting with a physiologically active macromolecule |
| 05/10/2007 | US20070105119 Method for detecting analytes by means of an analyte/polymeric activator bilayer arrangement |
| 05/10/2007 | US20070105118 Method for distinguishing aml subtypes with recurring genetic aberrations |
| 05/10/2007 | US20070105117 Method for in vitro evolution of polypeptides |
| 05/10/2007 | US20070105116 Metal complex type nucleic acid |
| 05/10/2007 | US20070105115 Promoter of the human fatp5 gene and uses |